In yesterday’s Wall Street session, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) shares traded at $7.16, up 1.13% from the previous session.
MRVI stock price is now -17.95% away from the 50-day moving average and -4.24% away from the 200-day moving average. The market capitalization of the company currently stands at $951.06M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $15, Craig Hallum recently initiated with Buy rating for Maravai LifeSciences Holdings Inc (NASDAQ: MRVI). On December 12, 2023, BofA Securities Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock reducing its target price from $10 to quote $8, while ‘KeyBanc Capital Markets’ rates the stock as ‘Sector Weight’
In other news, GTCR INVESTMENT XI LLC, Director sold 9,940,974 shares of the company’s stock on May 28 ’24. The stock was sold for $97,570,660 at an average price of $9.81. Upon completion of the transaction, the Director now directly owns 20,150,005 shares in the company, valued at $144.27 million. A total of 17.53% of the company’s stock is owned by insiders.
During the past 12 months, Maravai LifeSciences Holdings Inc has had a low of $4.52 and a high of $13.31. As of last week, the company has a debt-to-equity ratio of 1.37, a current ratio of 11.32, and a quick ratio of 10.47. The fifty day moving average price for MRVI is $8.715 and a two-hundred day moving average price translates $7.46095 for the stock.
The latest earnings results from Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) was released for 2024-03-31. The net profit margin was -47.81% and return on equity was -28.11% for MRVI. The company reported revenue of $64.18 million for the quarter, compared to $79.03 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -18.79 percent.
